DNAVSENLV• 3 Months (Normalized)
DNA vs ENLV (Ginkgo Bioworks Holdings Inc. vs Enlivex Ltd.)
Showing Closing Date Range from Jul 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DNA Performance $10.46
+%
Ginkgo Bioworks Holdings Inc.
Normalized Baseline0.00%
ENLV Performance $0.48
-94.09%
Enlivex Ltd.
Normalized Baseline0.00%
Alpha Spread Margin DNA LEADS
+94.09 pts
DNA outperforming by 94.09 percentage points
DNAENLV
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DNA ENLV
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | DNA Price | DNA Gain (%) | ENLV Price | ENLV Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $0.48 | -94.09% | - | |
| Sep 28, 2026 | $10.46 | +1.75% | $0.51 | -93.68% | +95.43% |
| Sep 25, 2026 | $10.66 | +3.70% | $0.60 | -92.64% | +96.34% |
| Sep 24, 2026 | $10.25 | -0.29% | $0.61 | -92.55% | +92.26% |
| Sep 23, 2026 | $8.58 | -16.54% | $0.64 | -92.13% | +75.59% |
| Sep 22, 2026 | $9.37 | -8.85% | $- | - | |
| Sep 21, 2026 | $7.98 | -22.37% | $0.69 | -91.48% | +69.11% |
| Sep 18, 2026 | $7.88 | -23.35% | $0.81 | -90.07% | +66.72% |
| Sep 17, 2026 | $7.84 | -23.74% | $0.73 | -91.06% | +67.32% |
| Sep 16, 2026 | $7.06 | -31.32% | $0.81 | -90.02% | +58.70% |
| Sep 15, 2026 | $6.99 | -32.00% | $0.88 | -89.14% | +57.14% |
| Sep 14, 2026 | $7.01 | -31.81% | $0.86 | -89.37% | +57.56% |
| Sep 11, 2026 | $6.75 | -34.34% | $0.96 | -88.19% | +53.85% |
| Sep 10, 2026 | $6.78 | -34.05% | $0.98 | -87.93% | +53.88% |
| Sep 09, 2026 | $6.79 | -33.95% | $1.04 | -87.21% | +53.26% |
Page 1 of 5